Skip to main content
Top
Published in: Journal of NeuroVirology 5/2021

01-10-2021 | Cerebral Sinus Venous Thrombosis | Review

A case-based systematic review on the SARS-COVID-2-associated cerebrovascular diseases and the possible virus routes of entry

Authors: Ali Lashkari, Reza Ranjbar

Published in: Journal of NeuroVirology | Issue 5/2021

Login to get access

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sparked a global pandemic that continues to affect various facets of human existence. Many sources reported virus-induced acute cerebrovascular disorders. Systematically, this paper reviews the case studies of COVID-19-related acute cerebrovascular diseases such as ischaemic stroke, intracerebral hemorrhage, and cerebral sinus thrombosis. We also spoke about how SARS-CoV-2 can infect the brain and trigger the aforementioned disorders. We stated that SARS-CoV-2 neuroinvasion and BBB dysfunction could cause the observed disorders; however, further research is required to specify the mechanisms and pathogenesis of the virus.
Literature
go back to reference Abbott NJ (2002) Astrocyte–endothelial interactions and blood–brain barrier permeability. J Anat 200(5):523–534CrossRef Abbott NJ (2002) Astrocyte–endothelial interactions and blood–brain barrier permeability. J Anat 200(5):523–534CrossRef
go back to reference Abdulkadir T, Ünlübaş Y, Alemdar M, Akyüz E (2020) Coexistence of COVID-19 and acute ischemic stroke report of four cases. J Clin Neurosci 77:227–229CrossRef Abdulkadir T, Ünlübaş Y, Alemdar M, Akyüz E (2020) Coexistence of COVID-19 and acute ischemic stroke report of four cases. J Clin Neurosci 77:227–229CrossRef
go back to reference Achar A, Ghosh C (2020) COVID-19-associated neurological disorders: the potential route of CNS invasion and blood-brain relevance. Cells 9(11):2360CrossRefPubMedCentral Achar A, Ghosh C (2020) COVID-19-associated neurological disorders: the potential route of CNS invasion and blood-brain relevance. Cells 9(11):2360CrossRefPubMedCentral
go back to reference Aghamollaei H, Sarvestani R, Bakherad H, Zare H, Guest PC, Ranjbar R, Sahebkar A (2021) Emerging technologies for the treatment of COVID-19. Clinical, Biological and Molecular Aspects of COVID-19, 81–96 Aghamollaei H, Sarvestani R, Bakherad H, Zare H, Guest PC, Ranjbar R, Sahebkar A (2021) Emerging technologies for the treatment of COVID-19. Clinical, Biological and Molecular Aspects of COVID-19, 81–96
go back to reference Agrawal K, Burger K, Rothrock JF (2016) Cerebral sinus thrombosis. Headache: The Journal of Head and Face Pain, 56(8)1380–1389 Agrawal K, Burger K, Rothrock JF (2016) Cerebral sinus thrombosis. Headache: The Journal of Head and Face Pain, 56(8)1380–1389
go back to reference Allahyari F, Hosseinzadeh R, Nejad JH, Heiat M, Ranjbar R (2021) A case report of simultaneous autoimmune and COVID-19 encephalitis. J Neurovirol 1–3 Allahyari F, Hosseinzadeh R, Nejad JH, Heiat M, Ranjbar R (2021) A case report of simultaneous autoimmune and COVID-19 encephalitis. J Neurovirol 1–3
go back to reference Allan SM, Rothwell NJ (2001) Cytokines and acute neurodegeneration. Nat Rev Neurosci 2(10):734–744CrossRefPubMed Allan SM, Rothwell NJ (2001) Cytokines and acute neurodegeneration. Nat Rev Neurosci 2(10):734–744CrossRefPubMed
go back to reference Benameur K, Agarwal A, Auld SC, Butters MP, Webster AS, Ozturk T, Schinazi RF (2020) Encephalopathy and encephalitis associated with cerebrospinal fluid cytokine alterations and coronavirus disease, Atlanta, Georgia, USA, 2020. Emerg Infect Dis 26(9):2016CrossRefPubMedPubMedCentral Benameur K, Agarwal A, Auld SC, Butters MP, Webster AS, Ozturk T, Schinazi RF (2020) Encephalopathy and encephalitis associated with cerebrospinal fluid cytokine alterations and coronavirus disease, Atlanta, Georgia, USA, 2020. Emerg Infect Dis 26(9):2016CrossRefPubMedPubMedCentral
go back to reference Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B, Fletcher RB (2020) Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv 6(31)eabc5801 Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B, Fletcher RB (2020) Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv 6(31)eabc5801
go back to reference Briguglio M, Bona A, Porta M, Dell’Osso B, Pregliasco FE, Banfi G (2020) Disentangling the hypothesis of host dysosmia and SARS-CoV-2: the bait symptom that hides neglected neurophysiological routes. Front Physiol 11:671CrossRefPubMedPubMedCentral Briguglio M, Bona A, Porta M, Dell’Osso B, Pregliasco FE, Banfi G (2020) Disentangling the hypothesis of host dysosmia and SARS-CoV-2: the bait symptom that hides neglected neurophysiological routes. Front Physiol 11:671CrossRefPubMedPubMedCentral
go back to reference Dahm T, Rudolph H, Schwerk C, Schroten H, Tenenbaum T (2016) Neuroinvasion and inflammation in viral central nervous system infections. Mediators of inflammation, 2016 Dahm T, Rudolph H, Schwerk C, Schroten H, Tenenbaum T (2016) Neuroinvasion and inflammation in viral central nervous system infections. Mediators of inflammation, 2016
go back to reference Daneman R, Prat A (2015) The blood–brain barrier. Cold Spring Harbor perspectives in biology, 7(1)a020412 Daneman R, Prat A (2015) The blood–brain barrier. Cold Spring Harbor perspectives in biology, 7(1)a020412
go back to reference Ehrlich LC, Hu S, Sheng WS, Sutton RL, Rockswold GL, Peterson PK, Chao CC (1998) Cytokine regulation of human microglial cell IL-8 production. J Immunol 160(4):1944–1948PubMed Ehrlich LC, Hu S, Sheng WS, Sutton RL, Rockswold GL, Peterson PK, Chao CC (1998) Cytokine regulation of human microglial cell IL-8 production. J Immunol 160(4):1944–1948PubMed
go back to reference Eliezer M, Hautefort C, Hamel AL, Verillaud B, Herman P, Houdart E, Eloit C (2020) Sudden and complete olfactory loss of function as a possible symptom of COVID-19. JAMA otolaryngology–head & neck surgery, 146(7)674–675 Eliezer M, Hautefort C, Hamel AL, Verillaud B, Herman P, Houdart E, Eloit C (2020) Sudden and complete olfactory loss of function as a possible symptom of COVID-19. JAMA otolaryngology–head & neck surgery, 146(7)674–675
go back to reference González RG, Hirsch JA, Koroshetz W, Lev MH, Schaefer PW (2011) Acute ischemic stroke: Springer González RG, Hirsch JA, Koroshetz W, Lev MH, Schaefer PW (2011) Acute ischemic stroke: Springer
go back to reference Grau AJ, Urbanek C, Palm F (2010) Common infections and the risk of stroke. Nat Rev Neurol 6(12):681–694CrossRefPubMed Grau AJ, Urbanek C, Palm F (2010) Common infections and the risk of stroke. Nat Rev Neurol 6(12):681–694CrossRefPubMed
go back to reference Halaji M, Farahani A, Ranjbar R, Heiat M, Dehkordi FS (2020) Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19. Infez Med 28(suppl 1):6–17PubMed Halaji M, Farahani A, Ranjbar R, Heiat M, Dehkordi FS (2020) Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19. Infez Med 28(suppl 1):6–17PubMed
go back to reference Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Liu F (2020) Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerging Microbes & Infections 9(1):1123–1130CrossRef Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Liu F (2020) Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerging Microbes & Infections 9(1):1123–1130CrossRef
go back to reference Hassett CE, Frontera JA (2021) Neurologic aspects of coronavirus disease of 2019 infection. Current opinion in infectious diseases Hassett CE, Frontera JA (2021) Neurologic aspects of coronavirus disease of 2019 infection. Current opinion in infectious diseases
go back to reference Heiat M, Heiat F, Halaji M, Ranjbar R, Yaali-Jahromi E, Azizi M, Badri T (2021) Phobia and fear of COVID-19: origins, complications and management, a narrative review. Ann Ig 33(4):360–370PubMed Heiat M, Heiat F, Halaji M, Ranjbar R, Yaali-Jahromi E, Azizi M, Badri T (2021) Phobia and fear of COVID-19: origins, complications and management, a narrative review. Ann Ig 33(4):360–370PubMed
go back to reference Hosseini MJ, Halaji M, Nejad JH, Ranjbar R (2021) Central nervous system vasculopathy associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a novel case report from Iran. J Neurovirol 1–3 Hosseini MJ, Halaji M, Nejad JH, Ranjbar R (2021) Central nervous system vasculopathy associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a novel case report from Iran. J Neurovirol 1–3
go back to reference Kirschenbaum D, Imbach LL, Rushing EJ, Frauenknecht KB, Gascho D, Ineichen BV, Reimann RR (2020) Intracerebral endotheliitis and microbleeds are neuropathological features of COVID‐19. Neuropathol Appl Neurobiol Kirschenbaum D, Imbach LL, Rushing EJ, Frauenknecht KB, Gascho D, Ineichen BV, Reimann RR (2020) Intracerebral endotheliitis and microbleeds are neuropathological features of COVID‐19. Neuropathol Appl Neurobiol
go back to reference Klopfenstein T, Kadiane-Oussou N, Toko L, Royer P-Y, Lepiller Q, Gendrin V, Zayet S (2020) Features of anosmia in COVID-19. Med Mal Infect 50(5):436–439CrossRefPubMedPubMedCentral Klopfenstein T, Kadiane-Oussou N, Toko L, Royer P-Y, Lepiller Q, Gendrin V, Zayet S (2020) Features of anosmia in COVID-19. Med Mal Infect 50(5):436–439CrossRefPubMedPubMedCentral
go back to reference Kumar A, Pareek V, Prasoon P, Faiq MA, Kumar P, Kumari C, Narayan RK (2020) Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients. J Neurosci Res 98(12):2376–2383CrossRefPubMed Kumar A, Pareek V, Prasoon P, Faiq MA, Kumar P, Kumari C, Narayan RK (2020) Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients. J Neurosci Res 98(12):2376–2383CrossRefPubMed
go back to reference Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang L (2020) Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581(7807):215–220CrossRefPubMed Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang L (2020) Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581(7807):215–220CrossRefPubMed
go back to reference Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1–e34CrossRefPubMed Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1–e34CrossRefPubMed
go back to reference Mandel M, Harari G, Gurevich M, Achiron A (2020) Cytokine prediction of mortality in COVID19 patients. Cytokine,134, 155190 Mandel M, Harari G, Gurevich M, Achiron A (2020) Cytokine prediction of mortality in COVID19 patients. Cytokine,134, 155190
go back to reference Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Wang D (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan. China JAMA Neurology 77(6):683–690CrossRefPubMed Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Wang D (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan. China JAMA Neurology 77(6):683–690CrossRefPubMed
go back to reference Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet 395(10229):1033–1034CrossRef Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet 395(10229):1033–1034CrossRef
go back to reference Meng X, Deng Y, Dai Z, Meng Z (2020) COVID-19 and anosmia: a review based on up-to-date knowledge. Am J Otolaryngol 102581 Meng X, Deng Y, Dai Z, Meng Z (2020) COVID-19 and anosmia: a review based on up-to-date knowledge. Am J Otolaryngol 102581
go back to reference Mirzaei R, Karampoor S, Sholeh M, Moradi P, Ranjbar R, Ghasemi F (2020) A contemporary review on pathogenesis and immunity of COVID-19 infection. Mol Biol Rep 47(7):5365–5376CrossRefPubMedPubMedCentral Mirzaei R, Karampoor S, Sholeh M, Moradi P, Ranjbar R, Ghasemi F (2020) A contemporary review on pathogenesis and immunity of COVID-19 infection. Mol Biol Rep 47(7):5365–5376CrossRefPubMedPubMedCentral
go back to reference Mirzaie A, Halaji M, Dehkordi FS, Ranjbar R, Noorbazargan H (2020) A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complement Ther Clin Pract 101214 Mirzaie A, Halaji M, Dehkordi FS, Ranjbar R, Noorbazargan H (2020) A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complement Ther Clin Pract 101214
go back to reference Mizuguchi M, Yamanouchi H, Ichiyama T, Shiomi M (2007) Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand 115:45–56CrossRefPubMed Mizuguchi M, Yamanouchi H, Ichiyama T, Shiomi M (2007) Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand 115:45–56CrossRefPubMed
go back to reference Mohammadpour S, Torshizi Esfahani A, Halaji M, Lak M, Ranjbar R (2021) An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19. J Cell Physiol 236(1):49–54PubMed Mohammadpour S, Torshizi Esfahani A, Halaji M, Lak M, Ranjbar R (2021) An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19. J Cell Physiol 236(1):49–54PubMed
go back to reference Pavillet CE, Selvakumar TA (2020) SARS-CoV-2 on the neural battleground. Nat Rev Immunol 20(9):518–518CrossRefPubMed Pavillet CE, Selvakumar TA (2020) SARS-CoV-2 on the neural battleground. Nat Rev Immunol 20(9):518–518CrossRefPubMed
go back to reference Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Wang W (2020) Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan. China Clinical Infectious Diseases 71(15):762–768CrossRefPubMed Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Wang W (2020) Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan. China Clinical Infectious Diseases 71(15):762–768CrossRefPubMed
go back to reference Robinson CP, Busl KM (2020) Neurologic manifestations of severe respiratory viral contagions. Critical care explorations 2(4) Robinson CP, Busl KM (2020) Neurologic manifestations of severe respiratory viral contagions. Critical care explorations 2(4)
go back to reference Rochfort KD, Collins LE, Murphy RP, Cummins PM (2014) Downregulation of blood-brain barrier phenotype by pro-inflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions. PloS One 9(7)e101815 Rochfort KD, Collins LE, Murphy RP, Cummins PM (2014) Downregulation of blood-brain barrier phenotype by pro-inflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions. PloS One 9(7)e101815
go back to reference Song E, Zhang C, Israelow B, Lu P, Weizman OE, Liu F, Wang G (2020) Neuroinvasive potential of SARS-CoV-2 revealed in a human brain organoid model. BioRxiv Song E, Zhang C, Israelow B, Lu P, Weizman OE, Liu F, Wang G (2020) Neuroinvasive potential of SARS-CoV-2 revealed in a human brain organoid model. BioRxiv
go back to reference Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, Sampaziotis F (2020) SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med 26(5):681–687CrossRefPubMedPubMedCentral Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, Sampaziotis F (2020) SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med 26(5):681–687CrossRefPubMedPubMedCentral
go back to reference Tu TM, Goh C, Tan YK, Leow AS, Pang YZ, Chien J, Koh J (2020) Cerebral venous thrombosis in patients with COVID-19 infection: a case series and systematic review. J Stroke Cerebrovasc Dis 105379 Tu TM, Goh C, Tan YK, Leow AS, Pang YZ, Chien J, Koh J (2020) Cerebral venous thrombosis in patients with COVID-19 infection: a case series and systematic review. J Stroke Cerebrovasc Dis 105379
go back to reference Varatharaj A, Galea I (2017) The blood-brain barrier in systemic inflammation. Brain Behav Immun 60:1–12CrossRefPubMed Varatharaj A, Galea I (2017) The blood-brain barrier in systemic inflammation. Brain Behav Immun 60:1–12CrossRefPubMed
go back to reference Wang L, He W, Yu X, Hu D, Bao M, Liu H, Jiang H (2020) Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect 80(6):639–645CrossRefPubMedPubMedCentral Wang L, He W, Yu X, Hu D, Bao M, Liu H, Jiang H (2020) Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect 80(6):639–645CrossRefPubMedPubMedCentral
go back to reference Wong C, Lam C, Wu A, Ip W, Lee N, Chan I, Chung S (2004) Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136: 95–103 In Wong C, Lam C, Wu A, Ip W, Lee N, Chan I, Chung S (2004) Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136: 95–103 In
go back to reference Zhang J, Sadowska GB, Chen X, Park SY, Kim JE, Bodge CA, Besio WG (2015) Anti-IL-6 neutralizing antibody modulates blood-brain barrier function in the ovine fetus. FASEB J 29(5):1739–1753CrossRefPubMedPubMedCentral Zhang J, Sadowska GB, Chen X, Park SY, Kim JE, Bodge CA, Besio WG (2015) Anti-IL-6 neutralizing antibody modulates blood-brain barrier function in the ovine fetus. FASEB J 29(5):1739–1753CrossRefPubMedPubMedCentral
go back to reference Zhu X, Liu Q, Du L, Lu L, Jiang S (2013) Receptor-binding domain as a target for developing SARS vaccines. J Thorac Dis 5(Suppl 2):S142PubMedPubMedCentral Zhu X, Liu Q, Du L, Lu L, Jiang S (2013) Receptor-binding domain as a target for developing SARS vaccines. J Thorac Dis 5(Suppl 2):S142PubMedPubMedCentral
go back to reference Ziegler CG, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, Hauser BM (2020) SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181(5)1016–1035.e1019 Ziegler CG, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, Hauser BM (2020) SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181(5)1016–1035.e1019
Metadata
Title
A case-based systematic review on the SARS-COVID-2-associated cerebrovascular diseases and the possible virus routes of entry
Authors
Ali Lashkari
Reza Ranjbar
Publication date
01-10-2021
Publisher
Springer International Publishing
Published in
Journal of NeuroVirology / Issue 5/2021
Print ISSN: 1355-0284
Electronic ISSN: 1538-2443
DOI
https://doi.org/10.1007/s13365-021-01013-8

Other articles of this Issue 5/2021

Journal of NeuroVirology 5/2021 Go to the issue